A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

Clinical trial NCT01313650 · COMPLETED

Trial details

NCT number: NCT01313650
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2011-03-01
Primary completion: 2012-04-01
Enrollment: 1538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.